NCT06252233Recruiting
Improvement of Quality of Life (QoL) Using Preference-Oriented QoLMonitoring in Patients with Lung Cancer
Improvement of Quality of Life (QoL) Using Preference-Oriented QoLMonitoring and Linkage with Clinical Registry Data: Randomised Clinical Trial in Patients with Lung Cancer
Source: ClinicalTrials.gov · Last updated 16 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of the study is to determine whether a preference-oriented quality of life monitoring with defined diagnostic and therapeutic options improves quality of life in patients with lung cancer during routine follow-up care.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 220 (estimated)
- First submitted
- 1 Feb 2024
- Start date
- 15 Feb 2024
- Primary completion date
- 15 Feb 2025
- Lead sponsor
- University of Bayreuth
- Diseases
- Lung cancer
- NCT number
- NCT06252233
What you commit to
- Study type: Interventional
- Planned participants: 220
- From 15 Feb 2024 to the primary completion date, 15 Feb 2025
- 8 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- age under 18 years;
Other
- unavailability of a study clinician for patient recruitment;
- patient misclassified in the candidate list (no primary diagnosis, no lung tumour);
- coordinating practitioner refuses trial participation;
- patient outside the defined study region (Germany, Bavaria: Upper Palatinate, Lower Bavaria, Upper Franconia);
- pregnancy/ breastfeeding;
- patient unable to fill out the QoL questionnaire (physical, psychological, cognitive, language reasons);
- patient refuses trial participation
Who the study is looking for
- primary diagnosis of lung cancer (ICD C33/C34, all stages)
- treatment in one of six recruiting hospitals treating patients with lung cancer (University Hospital Regensburg, Hospital Barmherzige Brüder Regensburg, Hospital Bayreuth, Hospital Coburg, Hospital Kulmbach, Hospital Bamberg);
- difference between date of histology and date of study entry not exceeding 2 months;
- informed consent;
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (8)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Klinikum Bamberg Coordinator of this site? Confirm its status | Bamberg | Germany | Recruiting |
| Hospital Bayreuth Coordinator of this site? Confirm its status | Bayreuth | Germany | Recruiting |
| Klinikum Coburg GmbH Coordinator of this site? Confirm its status | Coburg | Germany | Recruiting |
| Caritas Krankenhaus St. Maria Donaustauf Coordinator of this site? Confirm its status | Donaustauf | Germany | Recruiting |
| Klinikum Kulmbach Coordinator of this site? Confirm its status | Kulmbach | Germany | Recruiting |
| Universitätsklinikum Regensburg Coordinator of this site? Confirm its status | Regensburg | Germany | Recruiting |
| Krankenhaus Barmherzige Brüder Coordinator of this site? Confirm its status | Regensburg | Germany | Recruiting |
| Klinikum St. Elisabeth Straubing Coordinator of this site? Confirm its status | Straubing | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.